Actionnariat et activité des initiés pour C4 Therapeutics, Inc. (CCCC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.45 |
| Capitalisation | $381M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-10 | REYNO LEONARD | M-Exempt | 15,325 | |
| 2026-07-10 | REYNO LEONARD | F-InKind | 7,397 | $30K |
| 2026-07-01 | Anderson Kenneth Carl | A-Award | 2,650 | $12K |
| 2026-07-01 | GROGAN DONNA ROY | A-Award | 3,341 | $14K |
| 2026-06-24 | Hughes Owen | A-Award | 62,000 | $264K |
| 2026-06-24 | Hoerter Steven L. | A-Award | 62,000 | $264K |
| 2026-06-24 | Koppikar Utpal | A-Award | 62,000 | $264K |
| 2026-06-24 | Anderson Kenneth Carl | A-Award | 62,000 | $264K |
| 2026-06-24 | Cooper Ronald Harold Wilfred | A-Award | 62,000 | $264K |
| 2026-06-24 | Bessen Laura | A-Award | 62,000 | $264K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $36.3M | $90.5M | $181.7M | $76.1M | $29.8M | $126.6M | $55.5M | $74.6M |
| Placements à Court Terme | 0 | 0 | $190.0M | $233.2M | $246.4M | $127.1M | $189.4M | $173.9M |
| Créances | $86.4M | $4.6M | $4.5M | $5.7M | $1.5M | $11.8M | $3.1M | $2.4M |
| Stocks | 0 | 0 | 0 | 0 | -$61.0M | 0 | 0 | 0 |
| Actifs Courants | $123.5M | $96.8M | $381.0M | $325.7M | $287.6M | $271.2M | $257.8M | $258.1M |
| Immobilisations Corporelles | $20.4M | $18.9M | $16.6M | $35.1M | $77.5M | $71.1M | $63.4M | $45.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $146.5M | $118.3M | $400.1M | $506.8M | $430.8M | $376.5M | $349.6M | $359.1M |
| Dettes Fournisseurs | $1.2M | $5.4M | $5.7M | $4.5M | $1.2M | $1.4M | $1.3M | $858000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | $2.3M | 0 | 0 | 0 |
| Passifs Courants | $23.9M | $33.6M | $43.9M | $51.2M | $44.5M | $42.8M | $45.2M | $33.0M |
| Dette à Long Terme | 0 | 0 | $10.1M | $10.8M | $9.2M | 0 | 0 | 0 |
| Passifs Totaux | $226.2M | $230.2M | $119.3M | $117.2M | $141.6M | $130.3M | $133.6M | $102.5M |
| Réserves | -$83.4M | -$117.5M | -$183.8M | -$267.7M | -$395.9M | -$528.4M | -$633.7M | -$738.7M |
| Capitaux Propres | -$79.8M | -$112.0M | $280.8M | $389.6M | $289.2M | $246.1M | $216.0M | $256.6M |
| Dette Totale | $14.5M | $13.7M | $22.9M | $42.9M | $87.2M | $71.0M | $65.8M | $60.0M |
| Dette Nette | -$21.8M | -$76.8M | -$348.8M | -$266.4M | -$189.0M | -$182.7M | -$179.1M | -$188.6M |
| Fonds de Roulement | $99.6M | $63.1M | $337.2M | $274.4M | $243.0M | $228.4M | $212.6M | $225.1M |
Santé financière
| Dette / Capitaux propres | 0.23 |
| Ratio de liquidité | 5.45 |
Rentabilité
| Rentabilité des capitaux propres | -45.45% |
| Rentabilité du capital investi | -35.16% |
| Rentabilité des actifs | -28.22% |
| Marge brute | 94.86% |
| Marge opérationnelle | -318.97% |
| Marge nette | -289.44% |
Entreprises liées: ARMP · CDXS · CYBN · IMDX · MIST · MOLN · OABI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CCCC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions